Report Detail

Pharma & Healthcare Global Vaccines For Children (VFC) Market Outlook 2021

  • RnM4274767
  • |
  • 30 December, 2020
  • |
  • Global
  • |
  • 120 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Vaccines For Children (VFC) Market Overview

  • 1.1 Product Overview and Scope of Vaccines For Children (VFC)
  • 1.2 Vaccines For Children (VFC) Segment by Type
    • 1.2.1 Global Vaccines For Children (VFC) Sales Growth Rate Comparison by Type (2020-2026)
    • 1.2.2 Recombinant Vaccines
    • 1.2.3 Viral Vaccines
    • 1.2.4 Polysaccharide Vaccines
    • 1.2.5 Others
  • 1.3 Vaccines For Children (VFC) Segment by Application
    • 1.3.1 Vaccines For Children (VFC) Sales Comparison by Application: (2020-2026)
    • 1.3.2 Government Institution
    • 1.3.3 Private Sector
    • 1.3.4 Other
  • 1.4 Global Vaccines For Children (VFC) Market Size Estimates and Forecasts
    • 1.4.1 Global Vaccines For Children (VFC) Revenue 2015-2026
    • 1.4.2 Global Vaccines For Children (VFC) Sales 2015-2026
    • 1.4.3 Vaccines For Children (VFC) Market Size by Region: 2020 Versus 2026

2 Global Vaccines For Children (VFC) Market Competition by Manufacturers

  • 2.1 Global Vaccines For Children (VFC) Sales Market Share by Manufacturers (2015-2020)
  • 2.2 Global Vaccines For Children (VFC) Revenue Share by Manufacturers (2015-2020)
  • 2.3 Global Vaccines For Children (VFC) Average Price by Manufacturers (2015-2020)
  • 2.4 Manufacturers Vaccines For Children (VFC) Manufacturing Sites, Area Served, Product Type
  • 2.5 Vaccines For Children (VFC) Market Competitive Situation and Trends
    • 2.5.1 Vaccines For Children (VFC) Market Concentration Rate
    • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
    • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 2.7 Primary Interviews with Key Vaccines For Children (VFC) Players (Opinion Leaders)

3 Vaccines For Children (VFC) Retrospective Market Scenario by Region

  • 3.1 Global Vaccines For Children (VFC) Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global Vaccines For Children (VFC) Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America Vaccines For Children (VFC) Market Facts & Figures by Country
    • 3.3.1 North America Vaccines For Children (VFC) Sales by Country
    • 3.3.2 North America Vaccines For Children (VFC) Sales by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Vaccines For Children (VFC) Market Facts & Figures by Country
    • 3.4.1 Europe Vaccines For Children (VFC) Sales by Country
    • 3.4.2 Europe Vaccines For Children (VFC) Sales by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Vaccines For Children (VFC) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Vaccines For Children (VFC) Sales by Region
    • 3.5.2 Asia Pacific Vaccines For Children (VFC) Sales by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Vaccines For Children (VFC) Market Facts & Figures by Country
    • 3.6.1 Latin America Vaccines For Children (VFC) Sales by Country
    • 3.6.2 Latin America Vaccines For Children (VFC) Sales by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Vaccines For Children (VFC) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Vaccines For Children (VFC) Sales by Country
    • 3.7.2 Middle East and Africa Vaccines For Children (VFC) Sales by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Vaccines For Children (VFC) Historic Market Analysis by Type

  • 4.1 Global Vaccines For Children (VFC) Sales Market Share by Type (2015-2020)
  • 4.2 Global Vaccines For Children (VFC) Revenue Market Share by Type (2015-2020)
  • 4.3 Global Vaccines For Children (VFC) Price Market Share by Type (2015-2020)
  • 4.4 Global Vaccines For Children (VFC) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Vaccines For Children (VFC) Historic Market Analysis by Application

  • 5.1 Global Vaccines For Children (VFC) Sales Market Share by Application (2015-2020)
  • 5.2 Global Vaccines For Children (VFC) Revenue Market Share by Application (2015-2020)
  • 5.3 Global Vaccines For Children (VFC) Price by Application (2015-2020)

6 Company Profiles and Key Figures in Vaccines For Children (VFC) Business

  • 6.1 GSK
    • 6.1.1 Corporation Information
    • 6.1.2 GSK Description, Business Overview
    • 6.1.3 GSK Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.1.4 GSK Products Offered
    • 6.1.5 GSK Recent Development
  • 6.2 Sanofi
    • 6.2.1 Sanofi Corporation Information
    • 6.2.2 Sanofi Description, Business Overview
    • 6.2.3 Sanofi Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.2.4 Sanofi Products Offered
    • 6.2.5 Sanofi Recent Development
  • 6.3 Merck
    • 6.3.1 Merck Corporation Information
    • 6.3.2 Merck Description, Business Overview
    • 6.3.3 Merck Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.3.4 Merck Products Offered
    • 6.3.5 Merck Recent Development
  • 6.4 Pfizer
    • 6.4.1 Pfizer Corporation Information
    • 6.4.2 Pfizer Description, Business Overview
    • 6.4.3 Pfizer Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Pfizer Products Offered
    • 6.4.5 Pfizer Recent Development
  • 6.5 Jintan
    • 6.5.1 Jintan Corporation Information
    • 6.5.2 Jintan Description, Business Overview
    • 6.5.3 Jintan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.5.4 Jintan Products Offered
    • 6.5.5 Jintan Recent Development
  • 6.6 CSL
    • 6.6.1 CSL Corporation Information
    • 6.6.2 CSL Description, Business Overview
    • 6.6.3 CSL Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.6.4 CSL Products Offered
    • 6.6.5 CSL Recent Development
  • 6.7 MedImmune LLC
    • 6.6.1 MedImmune LLC Corporation Information
    • 6.6.2 MedImmune LLC Description, Business Overview
    • 6.6.3 MedImmune LLC Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 MedImmune LLC Products Offered
    • 6.7.5 MedImmune LLC Recent Development
  • 6.8 J&J(Crucell)
    • 6.8.1 J&J(Crucell) Corporation Information
    • 6.8.2 J&J(Crucell) Description, Business Overview
    • 6.8.3 J&J(Crucell) Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.8.4 J&J(Crucell) Products Offered
    • 6.8.5 J&J(Crucell) Recent Development
  • 6.9 China National Biotec
    • 6.9.1 China National Biotec Corporation Information
    • 6.9.2 China National Biotec Description, Business Overview
    • 6.9.3 China National Biotec Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.9.4 China National Biotec Products Offered
    • 6.9.5 China National Biotec Recent Development
  • 6.10 Tiantan
    • 6.10.1 Tiantan Corporation Information
    • 6.10.2 Tiantan Description, Business Overview
    • 6.10.3 Tiantan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.10.4 Tiantan Products Offered
    • 6.10.5 Tiantan Recent Development
  • 6.11 Hualan
    • 6.11.1 Hualan Corporation Information
    • 6.11.2 Hualan Vaccines For Children (VFC) Description, Business Overview
    • 6.11.3 Hualan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.11.4 Hualan Products Offered
    • 6.11.5 Hualan Recent Development
  • 6.12 Kangtai
    • 6.12.1 Kangtai Corporation Information
    • 6.12.2 Kangtai Vaccines For Children (VFC) Description, Business Overview
    • 6.12.3 Kangtai Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.12.4 Kangtai Products Offered
    • 6.12.5 Kangtai Recent Development
  • 6.13 Hissen
    • 6.13.1 Hissen Corporation Information
    • 6.13.2 Hissen Vaccines For Children (VFC) Description, Business Overview
    • 6.13.3 Hissen Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2015-2020)
    • 6.13.4 Hissen Products Offered
    • 6.13.5 Hissen Recent Development

7 Vaccines For Children (VFC) Manufacturing Cost Analysis

  • 7.1 Vaccines For Children (VFC) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Raw Materials Price Trend
    • 7.1.3 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Vaccines For Children (VFC)
  • 7.4 Vaccines For Children (VFC) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Vaccines For Children (VFC) Distributors List
  • 8.3 Vaccines For Children (VFC) Customers

9 Market Dynamics

  • 9.1 Market Trends
  • 9.2 Opportunities and Drivers
  • 9.3 Challenges
  • 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

  • 10.1 Global Vaccines For Children (VFC) Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Vaccines For Children (VFC) by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of Vaccines For Children (VFC) by Type (2021-2026)
  • 10.2 Vaccines For Children (VFC) Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Vaccines For Children (VFC) by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of Vaccines For Children (VFC) by Application (2021-2026)
  • 10.3 Vaccines For Children (VFC) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Vaccines For Children (VFC) by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of Vaccines For Children (VFC) by Region (2021-2026)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type, the Vaccines For Children (VFC) market is segmented into
    Recombinant Vaccines
    Viral Vaccines
    Polysaccharide Vaccines
    Others

    Segment by Application
    Government Institution
    Private Sector
    Other

    Global Vaccines For Children (VFC) Market: Regional Analysis
    The Vaccines For Children (VFC) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
    The key regions covered in the Vaccines For Children (VFC) market report are:
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    Global Vaccines For Children (VFC) Market: Competitive Analysis
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    The major players in global Vaccines For Children (VFC) market include:
    GSK
    Sanofi
    Merck
    Pfizer
    Jintan
    CSL
    MedImmune LLC
    J&J(Crucell)
    China National Biotec
    Tiantan
    Hualan
    Kangtai
    Hissen


    Summary:
    Get latest Market Research Reports on Vaccines For Children (VFC). Industry analysis & Market Report on Vaccines For Children (VFC) is a syndicated market report, published as Global Vaccines For Children (VFC) Market Outlook 2021. It is complete Research Study and Industry Analysis of Vaccines For Children (VFC) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,127.99
    3,191.99
    4,255.99
    2,390.42
    3,585.63
    4,780.84
    301,199.80
    451,799.70
    602,399.60
    212,110.93
    318,166.40
    424,221.86
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report